March 4, 2020 / 6:11 PM / a month ago

BRIEF-Geovax Provides Update On COVID-19 Vaccine Development Program

March 4 (Reuters) - GeoVax Labs Inc:

* GEOVAX PROVIDES UPDATE ON CORONAVIRUS (COVID-19) VACCINE DEVELOPMENT PROGRAM

* GEOVAX - USING ITS GV-MVA-VLP(TM) VACCINE PLATFORM TO CONSTRUCT VACCINE CANDIDATES USING GENETIC SEQUENCES FROM VIRUS RESPONSIBLE FOR COVID-19

* GEOVAX LABS INC - EXPECT A FASTER REGULATORY LICENSURE FOR CO’S COVID-19 VACCINE THAN FOR OTHER, UNPROVEN TECHNOLOGIES

* GEOVAX - IN JAN, ENTERED INTO LOI TO BEGIN COLLABORATION WITH BRAVOVAX, A VACCINE DEVELOPER IN WUHAN, CHINA, TO JOINTLY DEVELOP VACCINE FOR COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below